Project title: HCEMM Teaming National Laboratory – Phase 1
Start date: 1 May 2021
End date: 31 December 2022
Grant amount: € 2.550.000 (920.295.000 HUF)
National Laboratories are dynamic, institutionalizing, collaboration-based arenas of discovery and experimental research that open new, international dimensions and enable the social, economic, and environmental utilisation of research results.
The HCEMM National Laboratory has received a grant from the National Laboratories Programme (NLP), which was launched by the National Research, Development and Innovation Office, with the policy support of the Ministry for Innovation and Technology (for more information on NLP, visit https://nkfih.gov.hu/for-the-applicants/innovation-ecosystem/national-laboratories-programme).
The main goal of the HCEMM Teaming National Laboratory is to build a centre for Translational Medicine, which should eventually include all Hungarian sites which are engaged in this kind of research and development. The HCEMM activities are focused on translational medicine, the development of the clinical applications based on basic research results. An additional aim is to make the centre a regional hub for scientific excellence, training and employing highly qualified researchers, while being engaged in cutting-edge research in molecular medicine. HCEMM develops biomedical technology from early stage to clinical trials, either on its own or in partnership with industry and academia. Currently, two Clinical Phase 1 Trial Units are being developed in the HCEMM context, which will allow HCEMM groups to work with industry on a large scale.
Target groups of HCEMM Teaming National Laboratory are researchers from national, as well as international research institutes (academic and government) and the private sector, especially potential industrial partners, which will take new approaches for diagnostics and treatments from the proof-of-principle stage to commercial products.
Expected benefits from the Laboratory’s research activity:
HCEMM develops tools for the diagnostics, treatment and prevention of chronic and infectious diseases related to healthy ageing,
Licenses and exploits Intellectual property,
Works with Advanced Partner EMBL on developing an internationally competitive research and development environment for Translational Medicine in Hungary,
Strengthens knowledge-regions in Hungary and Central-Eastern Europe,
Engages the members of society on topics related to research on ageing-related diseases,
Strengthens the connection between industry and academy.